Advertisement
Advertisement
U.S. Markets open in 7 hrs 35 mins
Advertisement
Advertisement
Advertisement
Advertisement

Roche Holding AG (RHHBY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
49.35-0.17 (-0.33%)
At close: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close49.51
Open49.84
BidN/A x N/A
AskN/A x N/A
Day's Range49.08 - 49.94
52 Week Range39.80 - 51.05
Volume531,543
Avg. Volume794,073
Market Cap343.222B
Beta (5Y Monthly)0.27
PE Ratio (TTM)21.95
EPS (TTM)2.25
Earnings DateN/A
Forward Dividend & Yield1.22 (2.60%)
Ex-Dividend DateMar 18, 2021
1y Target Est52.44
  • GlobeNewswire

    Roche to launch SARS-CoV-2 & Flu A/B Rapid Antigen Test in countries accepting the CE Mark to enable rapid differentiation of viral respiratory infections

    The combination rapid antigen test quickly differentiates between SARS-CoV-2 and influenza viruses A and B infections, with results ready in less than 30 minutes, allowing informed decisions on patient and pandemic management decisionsAffordable and small, instrument-free testing kit enables convenient use for healthcare professionals at different point of care locations and in resource-limited settingsThe test works seamlessly with NAVIFY® Pass, Roche’s digital solution that allows individuals

  • Reuters

    Roche says Nestle Chairman Bulcke to leave its board of directors

    Roche board member Paul Bulcke, the current chairman of Nestle, will stand down from the Swiss drug-maker's board of directors after its annual general meeting next year, the company said on Friday. Bulcke, who has been a member the Roche board since 2011, decided not to stand for re-election at the AGM due to be held on March 22 next year, following almost 11 years in the role, Roche added. The Roche board has proposed Jemilah Mahmood, currently the Special Advisor on Public Health to Malaysia’s prime minister, for election as a new member.

  • GlobeNewswire

    Changes in the Board of Directors

    Professor Dr. Jemilah Mahmood portrait photo Portrait photo Basel, 3 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that at its December meeting the Board of Directors of Roche Holding Ltd has approved first proposals to the Annual General Meeting (AGM) scheduled for 15 March 2022. Mr Paul Bulcke, who has been serving on the Board of Directors since 2011, has decided not to stand for re-election at the AGM in 2022, following almost eleven years of tenure. The Board of Directo

Advertisement
Advertisement